2013 | Layered Voice Analysis 프로그램을 활용한 음성장애 환자의 스트레스 파라메터와 음성장애지수 간의 상관관계 | Thesis |
2019 | Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study | LANCET ONCOLOGY |
2023 | Lazertinib in pretreated EGFR T790M-mutated advanced non-small cell lung cancer: A real-world multicenter study | LUNG CANCER |
2023 | Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301 | JOURNAL OF CLINICAL ONCOLOGY |
2023 | Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301
| JOURNAL OF THORACIC ONCOLOGY |
2022 | Lazertinib: on the Way to Its Throne
| YONSEI MEDICAL JOURNAL |
2019 | LBA1_PR - Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study | ANNALS OF ONCOLOGY |
2019 | LBA4 - Effect of post-study immunotherapy (IO) on overall survival (OS) outcome in patients with metastatic (m) NSCLC treated with first-line durvalumab (D) vs chemotherapy (CT) in the Phase 3 MYSTIC study | ANNALS OF ONCOLOGY |
2022 | LBA7 A randomized, double-blind, multinational phase III study to assess the efficacy and safety of lazertinib versus gefitinib in the first-line treatment of patients with EGFR mutation (EGFRm), advanced NSCLC (LASER301; NCT04248829) | ANNALS OF ONCOLOGY |
2021 | LBEC0101, an etanercept biosimilar for the treatment of rheumatoid arthritis | EXPERT OPINION ON BIOLOGICAL THERAPY |
2021 | LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells
| AUTOPHAGY |
2021 | LCCL peptide cleavage after noise exposure exacerbates hearing loss and is associated with the monocyte infiltration in the cochlea | HEARING RESEARCH |
2002 | LCM positive 환자에서 plasmapheresis, IV gamma globulin 및 면역억제제를 병용하여 LCM 음성전환후 시행한 신장이식의 결과
| Journal of the Korean Society for Transplantation |
2014 | LD50 추정을 위한 방법론 비교
| Thesis |
2005 | LDA와 SVM 기반의 심실세동 검출에 관한 연구
| Thesis |
2018 | LDB2 regulates the expression of DLL4 through the formation of oligomeric complexes in endothelial cells
| BMB REPORTS |
2014 | LDL Cholesterol Affects Clinical Outcomes in Incident Hemodialysis Patients During the Early Stages of Dialysis | BLOOD PURIFICATION |
2005 | LDL 콜레스테롤 유전율과 유전자 분리모형 연구
| KOREAN CIRCULATION JOURNAL |
1999 | LDL-콜레스테롤 상승 환자에 대한 Atorva-statin의
유효성 및 안전성에 대한 연구
| Korean Circulation Journal (순환기) |
2000 | LDL-콜레스테롤 수준의 추정된 주유전자(putative major gene)에 관한 연구: 유전자 분리모형(segregation analysis) | Korean Journal of Epidemiology |